Macrophage metalloelastase (MMP-12) deficiency does not alter bleomycin-induced pulmonary fibrosis in mice

Boris Manoury1, Soazig Nenan, Isabelle Guenon

  • 1INSERM U620, Université de Rennes 1, Rennes, France. boris_manoury@hotmail.fr

Abstract

Insights

Mice lacking macrophage metalloelastase (MMP-12) showed no difference in lung fibrosis development after bleomycin exposure. This suggests MMP-12 is not a key factor in this model of pulmonary fibrosis.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Biochemistry

Background:

  • Pulmonary fibrosis involves excessive extracellular matrix deposition, leading to respiratory failure.
  • Metalloproteinases (MMPs) and their inhibitors (TIMPs) are implicated in fibrosis, but their precise roles are unclear.
  • Macrophage metalloelastase (MMP-12) is involved in pathological remodeling, yet its role in pulmonary fibrosis remains unknown.

Purpose of the Study:

  • To investigate the role of MMP-12 in bleomycin-induced pulmonary fibrosis.
  • To compare fibrotic responses in wild-type and MMP-12 deficient mice.

Main Methods:

  • Bleomycin was administered intranasally to C57BL/6, Balb/c, and MMP-12 deficient mice.
  • Lung fibrosis was assessed by collagen content, MMP activity, and gene/protein expression of mediators.
  • Bronchoalveolar lavage (BAL) and lung tissue analysis were performed 14 days post-administration.

Main Results:

  • Pulmonary fibrosis developed similarly in MMP-12 deficient and wild-type mice after bleomycin exposure.
  • MMP-12 expression was high in fibrosis-prone mice and low in fibrosis-resistant mice.
  • MMP-12 deficiency did not alter macrophage accumulation, collagen deposition, or levels of TGF-beta, MMP-2, and TIMP-1.

Conclusions:

  • MMP-12 deficiency does not significantly impact bleomycin-induced pulmonary fibrosis.
  • The study indicates MMP-12 is not a critical mediator in this specific model of lung fibrosis.

Related Concept Videos